Prevalence and number of circulating tumour cells and microemboli at diagnosis of advanced NSCLC.
about
Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future DirectionsCirculating Tumor Cell and Cell-free Circulating Tumor DNA in Lung CancerCirculating Plasma MicroRNAs As Diagnostic Markers for NSCLCCirculating tumor cells versus circulating tumor DNA in lung cancer-which one will win?Circulating tumor cell clusters: What we know and what we expect (Review).Spheroid Culture of Head and Neck Cancer Cells Reveals an Important Role of EGFR Signalling in Anchorage Independent SurvivalDetection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.Liquid Biopsy in Non-Small Cell Lung Cancer.Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions.New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer.Molecular characterization of circulating tumor cells in lung cancer: moving beyond enumeration.Expression of Epithelial Mesenchymal Transition and Cancer Stem Cell Markers in Circulating Tumor Cells.[Relationship between FGFR1 Gene Regulation of Circulating Tumor Cells and Clinical Features of Non-small Cell Lung Cancer].LncRNA Gm15290 promotes cell proliferation and invasion in lung cancer through directly interacting with and suppressing the tumor suppressor miR-615-5p
P2860
Q26781333-7C9A1270-2679-409F-897C-9BBC7659D4C2Q28067582-619C9635-A799-4518-B6CB-50AF0F7BA89FQ28073562-EACB4C63-DAD6-4E61-90FC-56B114CF5F31Q28077340-B4064F5B-5DCF-4544-BDD3-3488B9B06231Q30244106-A4D5D57D-CF07-4791-9221-F07951427536Q36137109-92CE66EE-7FE3-40B0-B31D-34C34E9386EEQ37377331-4A9771B5-805F-45E6-A0FD-4EF8416E9FF0Q39076207-95140664-E2D5-4C98-B363-44E4373DC269Q40206402-F68EA62A-D8D4-4A95-88A6-863F17D5D786Q41440995-8146F1E6-BD8E-4983-AF37-C8DBB3EBFEE4Q42371552-889E0A67-48B5-4544-AB14-9C3D4D9AC790Q47354317-F4C4772C-F498-4B8D-81B5-C25FB64F4715Q52864004-ECF8DA9E-C3C1-411D-9057-26C1DE1AA253Q55440995-E2E9B2CE-AE7B-4968-A883-EE457699DA52Q57024527-CD173AC5-5467-460E-8450-6633EDDB06DC
P2860
Prevalence and number of circulating tumour cells and microemboli at diagnosis of advanced NSCLC.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Prevalence and number of circu ...... t diagnosis of advanced NSCLC.
@en
Prevalence and number of circu ...... t diagnosis of advanced NSCLC.
@nl
type
label
Prevalence and number of circu ...... t diagnosis of advanced NSCLC.
@en
Prevalence and number of circu ...... t diagnosis of advanced NSCLC.
@nl
prefLabel
Prevalence and number of circu ...... t diagnosis of advanced NSCLC.
@en
Prevalence and number of circu ...... t diagnosis of advanced NSCLC.
@nl
P2093
P2860
P50
P1476
Prevalence and number of circu ...... at diagnosis of advanced NSCLC
@en
P2093
Alessandra Vella
Andrea Lopes Pegna
Cristina Maddau
Elena Bertelli
Luca Voltolini
Marco Nistri
Mario Mascalchi
Massimo Falchini
Pamela Pinzani
Stefania Zuccherelli
P2860
P2888
P304
P356
10.1007/S00432-015-2021-3
P577
2015-07-26T00:00:00Z